Evidence and AIDS activism: HIV scale-up and the contemporary politics of knowledge in global public health

Global Public Health

Volumn 9, Issue 1-2, 2014, Pages 57-72

  Colvin, Christopher J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

activism; antiretroviral treatment (ART); evidence; health policy; HIV AIDS

Indexed keywords

ANTI-RETROVIRAL AGENTS; CAPACITY BUILDING; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; PATIENT ADVOCACY; POLITICS; PUBLIC HEALTH; WORLD HEALTH;

EID: 84894343539     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2014.881519     Document Type: Article

References (43)

1. Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Taylor, D. (2010). Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329, 1168-1174. doi:10.1126/science.1193748
2. AVAC: Global Advocacy for HIV Prevention. (2010). A cascade of hope and questions: Understanding the results of CAPRISA 004. New York, NY: Author.
3. Baral, S., & Phaswana-Mafuya, N. (2012). Rewriting the narrative of the epidemiology of HIV in sub-Saharan Africa. SAHARA-J: Journal of Social Aspects of HIV/AIDS, 9(3), 127-130. doi:10.1080/17290376.2012.743787
4. Boulle, A., Clayden, P., Cohen, K., Cohen, T., Conradie, F., Dong, K., Wilson, D. (2010). Prolonged deferral of antiretroviral therapy in the SAPIT trial: Did we need a clinical trial to tell us that this would increase mortality? South African Medical Journal, 100, 566, 568, 570-561.
5. CDC. (2013). Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. MMWR Morbidity and Mortality Weekly Report, 62, 148-151. Atlanta, GA: Centers for Disease Control and Prevention.
6. Colvin, C. J., & Heywood, M. (2010). Negotiating ARV prices with pharmaceutical companies and the South African government: A civil society/legal approach. In E. Rosskam & I. Kickbusch (Eds.), Negotiating and navigating global health: Case studies in global health diplomacy (pp. 351-372). Hackensack, NJ: World Scientific.
7. Colvin, C. J., Konopka, S., & Chalker, J. (2013). A systematic review of health system barriers to and enablers of ART for pregnant and postpartum women with HIV. Washington, DC: Management Sciences for Health and USAID.
8. Coutsoudis, A., Goga, A., Desmond, C., Barron, P., Black, V., & Coovadia, H. (2013). Is option B+ the best choice? Lancet, 381, 269-271. doi:10.1016/S0140-6736(12)61807-8
9. Eaton, J. W., Hallett, T. B., & Garnett, G. P. (2011). Concurrent sexual partnerships and primary HIV infection: A critical interaction. AIDS and Behaviour, 15, 687-692. doi:10.1007/s10461-010-9787-8
10. Epstein, S. (1996). Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.
11. Geffen, N. (2013). World Health Organization guidelines should not change the CD4 count threshold for antiretroviral therapy initiation. South African Journal of HIV Medicine, 14(1), 6-7.
12. Georgeu, D., Colvin, C. J., Lewin, S., Fairall, L., Bachmann, M. O., Uebel, K., Bateman, E. D. (2012). Implementing nurse-initiated and managed antiretroviral treatment (NIMART) in South Africa: A qualitative process evaluation of the STRETCH trial. Implementation Science, 7, 66. doi:10.1186/1748-5908-7-66
13. Glenton, C., Colvin, C. J., Carlsen, B., Swartz, A., Lewin, S., Noyes, J., & Rashidian, A. (2013a). Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: Qualitative evidence synthesis (protocol). The Cochrane Library, 2. doi:10.1002/14651858.CD010414
14. Glenton, C., Colvin, C. J., Carlsen, B., Swartz, A., Lewin, S., Noyes, J., & Rashidian, A. (2013b). Barriers and facilitators to the implementation of lay health worker programmes to improve access to maternal and child health: Qualitative evidence synthesis. Cochrane Database of Systematic Reviews, 10, CD010414. doi:10.1002/14651858.CD010414.pub2
15. Haire, B., Folayan, M. O., Hankins, C., Sugarman, J., McCormack, S., Ramjee, G., & Warren, M. (2013). Ethical considerations in determining standard of prevention packages for HIV prevention trials: Examining PrEP. Developing World Bioethics, 13(2), 87-94. doi:10.1111/dewb.12032
16. Hallett, T. (2012). What mathematical models can tell us about prevention packages. Washington, DC: PEPFAR.
17. Kippax, S., Stephenson, N., Parker, R. G., & Aggleton, P. (2013). Between individual agency and structure in HIV prevention: Understanding the middle ground of social practice. American Journal of Public Health, 103: 1367-1375. doi:10.2105/AJPH.2013.301301
18. Knauft, B. M. (2006). Anthropology in the middle. Anthropological Theory, 6, 407-430. doi:10.1177/1463499606071594
19. Manderson, L., & Smith-Morris, C. (2010). Chronic conditions, fluid states: Chronicity and the anthropology of illness. New Brunswick, NJ: Rutgers University Press.
20. Marx, C., Halcli, A., & Barnett, C. (2012). Locating the global governance of HIV and AIDS: Exploring the geographies of transnational advocacy networks. Health and Place, 18, 490-495. doi:10.1016/j.healthplace.2012.02.006
21. Mayer-Schonberger, V., & Cukier, K. (2013). Big data: A revolution that will transform how we live, work, and think. New York, NY: Houghton Mifflin Harcourt.
22. Mills, E. J., Nachega, J. B., & Ford, N. (2013). Can we stop AIDS with antiretroviral-based treatment as prevention? Global Health: Science and Practice, 1(1), 29-34. doi:10.9745/GHSP-D-12-00053
23. MTN. (2012). MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women. Pittsburgh, PA: Microbicide Trials Network.
24. Mykhalovskiy, E., & Rosengarten, M. (2009). HIV/AIDS in its third decade: Renewed critique in social and cultural analysis: An introduction. Social Theory and Health, 7, 187-195. doi:10.1057/sth.2009.13
25. Mykhalovskiy, E., & Weir, L. (2004). The problem of evidence-based medicine: Directions for social science. Social Science and Medicine, 59, 1059-1069. doi:10.1016/j.socscimed.2003.12.002
26. Ncayiyana, D. J. (2011). The illusive promise of circumcision to prevent female-to-male HIV infection - not the way to go for South Africa. South African Medical Journal, 101, 775-776.
27. Nixon, S. A., Hanass-Hancock, J., Whiteside, A., & Barnett, T. (2011). The increasing chronicity of HIV in sub-Saharan Africa: Re-thinking 'HIV as a long-wave event' in the era of widespread access to ART. Global Health, 7, 41. doi:10.1186/1744-8603-7-41
28. Ogden, J., Gupta, G. R., Fisher, W. F., & Warner, A. (2011). Looking back, moving forward: Towards a game-changing response to AIDS. Global Public Health, 6, S285-S292. doi:10.1080/17441692.2011.621966
29. Ogden, J., Gupta, G. R., Warner, A., & Fisher, W. F. (2011). Revolutionising the AIDS response. Global Public Health, 6, S383-S395. doi:10.1080/17441692.2011.621965
30. Robins, S. (2003). Grounding 'globalisation from below': 'Global citizens' in local spaces. In D. Chidester, W. G. James, & P. Dexter (Eds.), What holds us together: Social cohesion in South Africa (pp. 242-273). Johannesburg: HSRC Press.
31. Robins, S. (2005). From 'medical miracles' to normal(ised) medicine: AIDS treatment, activism and citizenship in the UK and South Africa (IDS Working Papers). Brighton: Institute for Development Studies, Sussex University.
32. Sauerborn, R., Nitayarumphong, S., & Gerhardus, A. (1999). Strategies to enhance the use of health systems research for health sector reform. Tropical Medicine & International Health, 4, 827-835. doi:10.1046/j.1365-3156.1999.00497.x
33. Seckinelgin, H. (2012). The global governance of success in HIV/AIDS policy: Emergency action, everyday lives, and Sen's capabilities. Health and Place, 18, 453-460. doi:10.1016/j.healthplace.2011.09.014
34. Seeley, J., Watts, C. H., Kippax, S., Russell, S., Heise, L., & Whiteside, A. (2012). Addressing the structural drivers of HIV: A luxury or necessity for programmes? Journal of the International AIDS Society, 15(1), 1-4. doi:10.1186/1758-2652-15-1
35. Sidibe, M. (2011). Letter to partners 2011. Geneva: UNAIDS.
36. Solomon, M. (2011). Just a paradigm: Evidence-based medicine in epistemological context. European Journal for Philosophy of Science, 1, 451-466. doi:10.1007/s13194-011-0034-6
37. Stein, Z., & Susser, I. (2010). Transparency, accountability and feminist science: What next for microbicide trials? Cape Town: AIDS Legal Network and ATHENA Network.
38. TAC. (2013). Systematic problems in drug supply have to be addressed now to avert future crisis TAC Electronic Newsletter. Cape Town: Treatment Action Campaign.
39. UNICEF. (2012). Options B and B+: Key considerations for countries to implement at equity-focused approach. New York, NY: Author.
40. Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. New England Journal of Medicine, 367, 411-422. doi:10.1056/NEJMoa1202614
41. Wachter, R. M. (1992). AIDs, activism, and the politics of health. New England Journal of Medicine, 326(2), 128-133. doi:10.1056/NEJM199201093260209
42. Wamai, R. G., Morris, B. J., Bailis, S. A., Sokal, D., Klausner, J. D., Appleton, R., Banerjee, J. (2011). Male circumcision for HIV prevention: Current evidence and implementation in sub-Saharan Africa. Journal of the International AIDS Society, 14, 49. doi:10.1186/1758-2652-14-49
43. Wandeler, G., Keiser, O., Pfeiffer, K., Pestilli, S., Fritz, C., Labhardt, N. D., Ehmer, J. (2012). Outcomes of antiretroviral treatment programs in rural Southern Africa. Journal of Acquired Immune Deficiency Syndrome, 59, e9-e16. doi:10.1097/QAI.0b013e31823edb6a